Jamie Thimesch, NP
Nurse Practitioner · Pratt, KSNPI 1730744863
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,996 of the $2,272 with a category attached, or 87.8%. 22 manufacturers reported payments, led by Astellas Pharma US Inc at 27.9% of the total. Reporting peaked in 2023 at $925 and has fallen 65.7% since, to $318 in 2025.
Across 103 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$635
- Sumitomo Pharma America, Inc.$274
- Hologic Sales And Service, LLC$209
- Bayer$186
- AbbVie$169
- Pfizer$107
- plus $691 from 16 others
What the payments were for
- Food & beverage$1,99688%
- Education$27712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 21 | $635 |
| Sumitomo Pharma America, Inc. | 13 | $274 |
| Hologic Sales And Service, LLC | 8 | $209 |
| Bayer | 8 | $186 |
| AbbVie | 9 | $169 |
| Pfizer | 7 | $107 |
| Novo Nordisk | 6 | $96 |
| Myovant Sciences Inc. | 5 | $95 |
| Agile Therapeutics, Inc. | 4 | $74 |
| Dexcom, Inc. | 4 | $74 |
| Biogen | 3 | $67 |
| Exeltis, USA Inc. | 4 | $62 |
| Mayne Pharma Commercial LLC | 2 | $38 |
| Gynesonics, Inc. | 1 | $38 |
| Vertex | 1 | $26 |
| BD | 1 | $23 |
| Minerva Surgical, Inc | 1 | $22 |
| Avanos Medical | 1 | $19 |
| Shield Therapeutics Inc | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Sage Therapeutics, LLC | 1 | $13 |
How this compares
$2,272 in reported general payments places this provider in the 85th percentile of 1,326 nurse practitioner providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 28 | $994 |
| LyllanaEstradiol | 11 | $368 |
| ProgesteroneProgesterone, Micronized | 13 | $290 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Pratt
- Gary GrafTopeka$726K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
- Michelle KirkHutchinson$58K
- Catherine PowellWichita$50K
- Lori RanalloWestwood$48K
- Kristyn MilburnPleasanton$23K
- Kelli BradburyTopeka$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.